Chimpanzee testicular tissue

animal tissue

provenance:animal tissue

first introduced:1920

regulatory status:banned

context:Voronoff used chimpanzee testicular tissue as graft material from June 1920. He maintained a private primate colony at Château Grimaldi (near Menton, on the French Riviera) to supply surgical material on demand. Earlier work used domestic ungulates (sheep, goats, cattle); the choice of chimpanzee reflected the assumed phylogenetic proximity to humans and the implied better immunological compatibility, a premise not borne out by subsequent immunology research.

MECHANISM CLAIMED

Live chimpanzee testicular tissue, when surgically implanted under the human scrotal skin, integrates with the recipient and provides ongoing endocrine and cellular contribution that reverses biological aging.

MECHANISM ACTUAL

Xenografted primate tissue is recognized as foreign and rejected by the recipient's immune system within days to weeks. No sustained endocrine contribution from the graft is biologically possible; reported clinical effects are consistent with placebo, surgical-attention bias, and patient self-report. The hypothesis that Voronoff's xenografts contributed to the cross-species transmission of HIV has been examined and rejected by modern review (Bajic et al, *Xenotransplantation* 2012).

INTERVENTIONS USING IT

Voronoff testicular xenograft (chimpanzee-to-human)

NOTES

Chimpanzee testicular tissue was the active material in Voronoff’s xenograft protocol from 1920 to the mid-1930s. The supply chain ran through Voronoff’s private primate colony at Grimaldi; chimpanzees were killed on demand to provide fresh tissue for surgery. The use of primate tissue in human transplantation is now heavily restricted under international xenotransplantation policy and ethics frameworks. The ingredient is the direct historical precursor to the fetal lamb tissue used by Niehans (1931) and to the donor plasma and IVIG used in modern TPE protocols (2024-present); the underlying logic, biological-substance transfer from a presumed-young donor to a paying older recipient, recurs across the lineage with the donor material updated to the biology of each era.